Gri bio (nasdaq: gri) bolsters patent portfolio

- u.s. p atent i ssuance for l ead p rogram, gri-0621 , i n development for the treatment of idiopathic pulmonary fibrosis (ipf )
GRI Ratings Summary
GRI Quant Ranking